Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technologies to basic science cancer researchers – to create an environment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imaging adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

Immune Cells Engineered to Signal when Cancer is Detected

March 18, 2019

New Technique Allows Drug Delivery to Specific Brain Regions

March 1, 2019

Mehdi Razavi Announced Winner of Stanford Bio-X Poster Session

February 15, 2019

Dr. Grant Provides Novel, Less Invasive Treatment for Seizure

February 14, 2019

Marc Stevens Awarded MIYI Prize

January 28, 2019

MIPS Research Utilizes Gold Nanoprisms Capable of Imaging Down to Single Cell

December 13, 2018

Dr. Gambhir and Dr. Wu Recognized as Highly Cited Researchers of 2018

December 3, 2018